We are live on ! Find out more
NCM

Novare Capital Management Portfolio holdings

AUM $1.26B
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
-0.74%
1 Year Est. Return
+20.28%
3 Year Est. Return
+65.67%
5 Year Est. Return
+78.77%
10 Year Est. Return
+251.06%
AUM
$405M
AUM Growth
+$1.43M
Cap. Flow
+$5.66M
Cap. Flow %
1.4%
Top 10 Hldgs %
23.57%
Holding
117
New
4
Increased
45
Reduced
48
Closed
8

Top Sells

Rank Stock Value
1
NSC icon
Norfolk Southern
NSC
+$5.45M
2
VTRS icon
Viatris
VTRS
+$3.14M
3
EMCI
EMC INS Group Inc
EMCI
+$2.6M
4
EMR icon
Emerson Electric
EMR
+$1.15M
5
GPN icon
Global Payments
GPN
+$1.13M

Sector Composition

Rank Sector Weight
1 Energy 22.31%
2 Healthcare 12.71%
3 Financials 10.67%
4 Industrials 8.17%
5 Consumer Discretionary 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPD icon
1
Enterprise Products Partners
EPD
$82.5B
$15.1M 3.72%
504,041
-1,832
-0.4% -$60K
AAPL icon
2
Apple
AAPL
$4.95T
$10.8M 2.67%
344,620
-840
-0.2% -$26.9K
CVS icon
3
CVS Health
CVS
$137B
$10.1M 2.5%
96,739
-1,750
-2% -$179K
PRF icon
4
Invesco FTSE RAFI US 1000 ETF
PRF
$9.76B
$8.94M 2.2%
492,965
+2,185
+0.4% +$40.6K
MMP
5
DELISTED
Magellan Midstream Partners, L.P.
MMP
$8.71M 2.15%
118,743
-847
-0.7% -$68K
SPY icon
6
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$8.3M 2.05%
40,342
+4,213
+12% +$886K
CMCSA icon
7
Comcast
CMCSA
$80.9B
$7.97M 1.96%
264,918
+6,768
+3% +$199K
BRK.B icon
8
Berkshire Hathaway Class B
BRK.B
$1.07T
$7.31M 1.8%
53,687
+1,781
+3% +$254K
MET icon
9
MetLife
MET
$61.2B
$7.22M 1.78%
144,630
+5,408
+4% +$256K
GPN icon
10
Global Payments
GPN
$23B
$7.18M 1.77%
138,886
-22,040
-14% -$1.13M
ETP
11
DELISTED
Energy Transfer Partners, L.P.
ETP
$7.07M 1.74%
185,790
FDX icon
12
FedEx
FDX
$73.5B
$7.07M 1.74%
41,460
+4,755
+13% +$827K
HON icon
13
Honeywell
HON
$77.9B
$7.02M 1.73%
76,586
+2,748
+4% +$256K
VFC icon
14
VF Corp
VFC
$6.72B
$7M 1.73%
106,661
+6,701
+7% +$453K
QCOM icon
15
Qualcomm
QCOM
$179B
$6.97M 1.72%
111,326
+3,955
+4% +$270K
VTRS icon
16
Viatris
VTRS
$20.5B
$6.89M 1.7%
101,592
-44,494
-30% -$3.14M
AGN
17
DELISTED
Allergan plc
AGN
$6.85M 1.69%
22,581
-292
-1% -$87.1K
COP icon
18
ConocoPhillips
COP
$141B
$6.82M 1.68%
111,128
+3,091
+3% +$201K
NS
19
DELISTED
NuStar Energy L.P.
NS
$6.8M 1.68%
114,611
-400
-0.3% -$25.3K
ETN icon
20
Eaton
ETN
$155B
$6.74M 1.66%
99,906
-3,035
-3% -$214K
ETP
21
DELISTED
Energy Transfer Partners L.p.
ETP
$6.61M 1.63%
126,629
+15,755
+14% +$879K
ET icon
22
Energy Transfer Partners
ET
$68.5B
$6.61M 1.63%
205,954
-2
-0% -$67
IJH icon
23
iShares Core S&P Mid-Cap ETF
IJH
$123B
$6.36M 1.57%
211,975
+5,065
+2% +$154K
WP
24
DELISTED
Worldpay, Inc.
WP
$6.35M 1.57%
166,200
-2,985
-2% -$118K
DIS icon
25
Walt Disney
DIS
$168B
$6.29M 1.55%
55,062
-2,585
-4% -$284K

Similar funds

Novare Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Novare Capital Management held 117 positions worth $405M, up 0.35% from $404M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Novare Capital Management's Q2 2015 filing shows 4 new, 45 increased, 48 reduced and 8 closed positions. Its largest new stake was Aptiv: 68,705 shares worth $5.85M. The largest sale was Norfolk Southern, an estimated $5.45M.

By sector, the portfolio is most concentrated in Energy at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Novare Capital Management's largest Q2 2015 buy was Aptiv: 68,705 shares worth $5.85M.
  • Novare Capital Management added most to Vanguard FTSE Emerging Markets ETF in Q2 2015, an estimated $1.3M increase.
  • Novare Capital Management's biggest Q2 2015 reduction was Viatris, cutting an estimated $3.14M.
  • Novare Capital Management fully exited Norfolk Southern in Q2 2015, selling an estimated $5.45M.
  • Novare Capital Management's ten largest holdings make up 24% of its $405M portfolio in Q2 2015.
  • Novare Capital Management opened 4 new positions and closed 8 in Q2 2015.
  • Novare Capital Management's portfolio value rose 0.35% quarter-over-quarter to $405M.

Based on Novare Capital Management's 13F filing for Q2 2015, filed 13 Aug 2015.